Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

MeSH Review:

Insurance Carriers

DeGood, D.E. et al., Dickinson, T. et al., Seoud, M.A. et al., Kauff, N.D. et al., Avery, S. et al.

Dickinson, Riley, Zabetakis,

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

High impact information on Insurance Carriers

This paradox may be due to the lesser chronicity of the RSD patients as well as to their apparently experiencing a more sympathetic response from doctors, employers, and insurance carriers than their LBP and HAP counterparts [1].
SETTING: Patients (all with private insurance carriers) enrolled in an academic IVF program (The Jones Institute for Reproductive Medicine) [2].
CONCLUSION: Insurance carriers reimbursed the vast majority of BRCA mutation carriers undergoing risk-reducing surgery [3].
Medical information technology companies like Solucient and insurance carriers such as Blue Cross of California have identified and published a list of hospitals that demonstrate superior quality and patient outcomes for CABG procedures [4].
Thinking of affiliation? How insurance carriers evaluate potential PPO partners [5].

References

A psychosocial and behavioral comparison of reflex sympathetic dystrophy, low back pain, and headache patients. DeGood, D.E., Cundiff, G.W., Adams, L.E., Shutty, M.S. Pain (1993) [Pubmed]
Outcome of twin, triplet, and quadruplet in vitro fertilization pregnancies: the Norfolk experience. Seoud, M.A., Toner, J.P., Kruithoff, C., Muasher, S.J. Fertil. Steril. (1992) [Pubmed]
Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations. Kauff, N.D., Scheuer, L., Robson, M.E., Glogowski, E., Kelly, B., Barakat, R., Heerdt, A., Borgen, P.I., Davis, J.G., Offit, K. Genet. Med. (2001) [Pubmed]
External validation of compliance to perfusion quality indicators. Dickinson, T., Riley, J., Zabetakis, P.M. Perfusion (2004) [Pubmed]
Thinking of affiliation? How insurance carriers evaluate potential PPO partners. Avery, S., Mangano, L. AAPPO journal : the journal of the American Association of Preferred Provider Organizations. (1992) [Pubmed]

Contributions to this collaborative article are from individual authors of WikiGenes or mined by the WikiGenes Data Mining Engine from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use

[search][advanced]